Brought to you by 
Warburg Pincus to buy eye care giant Bausch & Lomb for $4.5bn
24 Sep 2007
Executive Summary
After coming under scrutiny for a dangerous eye infection associated with its key brand ReNu with Moisture Loc, and exactly one year after taking the controversial contact lens solution off the worldwide market, ophthalmic company Bausch & Lomb announced it is being bought by Warburg Pincus in a deal valued at $4.5bn.
Deal Industry
- Pharmaceuticals
-
Pharmaceuticals
- Generic Drugs
- OTC, Consumer
-
Medical Devices
- Implantable Devices
- Surgical Equipment & Devices
Deal Status
- Final
Deal Type
-
Acquisition
- Buy-out
- Full Acquisition
- Payment Includes Cash
Already a Biomedtracker subscriber?
You have access to the full deal record through your subscription
Want to become a subscriber?
Subscribers get more deal details, updates, deal financials and deal products.
Questions?
Questions?
Please contact Sales at: (212) 520-2765 or email [email protected]
Related Companies
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Warburg Pincus to buy eye care giant Bausch & Lomb for $4.5bn
Email Deal
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice